Literature DB >> 32051960

Laparoscopic hepatectomy in a patient with uncontrolled polycythaemia vera.

T R Riekki1, E Ling1, D Cordovani1.   

Abstract

This case report describes the peri-operative course of a patient with uncontrolled polycythaemia vera who underwent a laparoscopic hepatectomy for intrahepatic cholangiocarcinoma. Polycythaemia vera is a chronic condition that results in erythrocytosis and puts patients at risk of peri-operative complications including thrombotic events and paradoxical haemorrhage. Little evidence exists on the ideal peri-operative management of uncontrolled polycythaemia vera when the proposed procedure carries a high risk of haemorrhage. Our patient presented with a pre-operative haemoglobin of 197 g.l-1 (haematocrit 65%) and was not phlebotomised pre-operatively. Intra-operatively he lost 2700 ml of blood, reducing his haematocrit to 48%, and then suffered fatal thrombotic complications postoperatively. The patient did not receive any blood product transfusions during his peri-operative course. We review the available evidence to guide the peri-operative management of patients with polycythaemia vera. The inherent risks of thrombosis and haemorrhage associated with polycythaemia vera need to be weighed against the specific surgical and transfusion-related risks. Phlebotomy to achieve a pre-operative haematocrit under 45% is recommended and intra-operative phlebotomy shows promise for reducing blood loss during hepatectomies. Management of postoperative erythrocytosis may be an important and underappreciated aspect of reducing the peri-operative risk of thrombosis in patients with polycythaemia vera.
© 2019 Association of Anaesthetists.

Entities:  

Keywords:  antithrombotic drugs: pre‐operative management; blood oxygen transport; pulmonary embolism

Year:  2019        PMID: 32051960      PMCID: PMC6931284          DOI: 10.1002/anr3.12030

Source DB:  PubMed          Journal:  Anaesth Rep        ISSN: 2637-3726


  10 in total

1.  SURGICAL BLEEDING IN POLYCYTHEMIA VERA.

Authors:  L R WASSERMAN; H S GILBERT
Journal:  Ann N Y Acad Sci       Date:  1964-07-09       Impact factor: 5.691

2.  Perioperative blood product administration and thromboembolic events in patients with treated polycythemia vera: a case-control study.

Authors:  Toby N Weingarten; Ryan E Hofer; Barrett J Ahle; Keri M Kemp; Jacinta A Nkwonta; Bradly J Narr; Animesh Pardanani; Darrell R Schroeder; Juraj Sprung
Journal:  Transfusion       Date:  2015-02-27       Impact factor: 3.157

Review 3.  Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation.

Authors:  R Landolfi; L Di Gennaro; A Falanga
Journal:  Leukemia       Date:  2008-09-18       Impact factor: 11.528

4.  Hypovolemic phlebotomy in liver surgery is associated with decreased red blood cell transfusion.

Authors:  Laura Baker; Sean Bennett; Janelle Rekman; Aklile Workneh; Christopher Wherrett; Jad Abou-Khalil; Kimberly A Bertens; Fady K Balaa; Guillaume Martel
Journal:  HPB (Oxford)       Date:  2018-11-28       Impact factor: 3.647

5.  Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management.

Authors:  Ayalew Tefferi; Tiziano Barbui
Journal:  Am J Hematol       Date:  2018-11-09       Impact factor: 10.047

6.  Cardiovascular events and intensity of treatment in polycythemia vera.

Authors:  Roberto Marchioli; Guido Finazzi; Giorgina Specchia; Rossella Cacciola; Riccardo Cavazzina; Daniela Cilloni; Valerio De Stefano; Elena Elli; Alessandra Iurlo; Roberto Latagliata; Francesca Lunghi; Monia Lunghi; Rosa Maria Marfisi; Pellegrino Musto; Arianna Masciulli; Caterina Musolino; Nicola Cascavilla; Giovanni Quarta; Maria Luigia Randi; Davide Rapezzi; Marco Ruggeri; Elisa Rumi; Anna Rita Scortechini; Simone Santini; Marco Scarano; Sergio Siragusa; Antonio Spadea; Alessia Tieghi; Emanuele Angelucci; Giuseppe Visani; Alessandro Maria Vannucchi; Tiziano Barbui
Journal:  N Engl J Med       Date:  2012-12-08       Impact factor: 91.245

7.  Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey.

Authors:  Marco Ruggeri; Francesco Rodeghiero; Alberto Tosetto; Giancarlo Castaman; Francesca Scognamiglio; Guido Finazzi; Federica Delaini; Caterina Micò; Alessandro M Vannucchi; Elisabetta Antonioli; Valerio De Stefano; Tommaso Za; Luigi Gugliotta; Alessia Tieghi; Maria Gabriella Mazzucconi; Cristina Santoro; Tiziano Barbui
Journal:  Blood       Date:  2007-10-01       Impact factor: 22.113

8.  Acute coronary artery bypass graft failure in a patient with polycythemia vera.

Authors:  Hiroaki Osada; Hiroyuki Nakajima; Katsuaki Meshii; Motoaki Ohnaka
Journal:  Asian Cardiovasc Thorac Ann       Date:  2014-09-04

Review 9.  A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline.

Authors:  Mary F F McMullin; Adam J Mead; Sahra Ali; Catherine Cargo; Frederick Chen; Joanne Ewing; Mamta Garg; Anna Godfrey; Steven Knapper; Donal P McLornan; Jyoti Nangalia; Mallika Sekhar; Frances Wadelin; Claire N Harrison
Journal:  Br J Haematol       Date:  2018-11-13       Impact factor: 6.998

10.  Anesthetic management of a patient with polycythemia vera undergoing emergency repair of a type-A aortic dissection and concomitant coronary artery bypass grafting: a case report.

Authors:  Hyeongwoo Im; Jeong Jin Min; Jaeyoung Yang; Sangmin Maria Lee; Jong Hwan Lee
Journal:  Korean J Anesthesiol       Date:  2015-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.